Skip to Content

WATSON 698 200 (Hydroxychloroquine Sulfate 200 mg)

Pill with imprint WATSON 698 200 is White, Elliptical / Oval and has been identified as Hydroxychloroquine Sulfate 200 mg. It is supplied by Actavis Pharma, Inc..

Hydroxychloroquine is used in the treatment of lyme disease, arthritis; dermatomyositis; malaria; malaria prevention; rheumatoid arthritis and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 698 200

Hydroxychloroquine sulfate 200 mg WATSON 698 200
Hydroxychloroquine sulfate 200 mg WATSON 698 200
Hydroxychloroquine sulfate 200 mg WATSON 698 200
Hydroxychloroquine sulfate 200 mg WATSON 698 200

Hydroxychloroquine Sulfate

Imprint
WATSON 698 200
Strength
200 mg
Color
White
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antimalarial quinolines, Antirheumatics
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-3041
Inactive Ingredients
silicon dioxide, dextrates, magnesium stearate, maltodextrin, microcrystalline cellulose, polydextrose, sodium starch glycolate type A potato, corn starch, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.